Pharma stocks face Q4 reality check amid global headwinds

Analysts expect modest revenue growth but pressure on profitability in the March quarter

Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities

PMDA is regarded among the most stringent regulatory bodies globally

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage

Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.

Merck bags EU nod for infant RSV protection in major public health milestone

ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence

Salve Group launches Parasoft foot cream to address dry and cracked feet

This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture

NIFTY Pharma shows stable trend amid cautious market sentiment

Muted movement reflects consolidation phase as investors await earnings triggers

Moberg Pharma reports 2025 annual results, maintains strong cash position

The company reported net revenue of SEK 13.5 million for the full year 2025

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%

Telangana launches Project Sanjeevani, India’s first integrated highway trauma rescue protocol on NH-44

Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response

Anlon Healthcare gets Brickwork rating withdrawal after facility closure

This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities

C-mo wins CE Mark for AI-powered cough monitoring device, targets clinical trials market

The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance

Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation

Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms

Vetter ramps up global clinical manufacturing push with major US & Europe expansion

The goal is to better support drug developers as programs move from laboratory research into clinical trials

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps

New guidance aims to speed up diagnosis of childhood abdominal cancers

Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study

The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation

GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen

GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access